Medtronic is taking another shot at renal denervation to treat drug-resistant hypertension, a year after a pivotal trial for its key product in the space failed to meet its efficacy endpoint.
Vector is Children's Hospital Boston's blog about research and innovation in pediatric and adult medicine. We report and comment on medical innovations and advances – from bench to bedside – touching on scientific, business and policy issues. Our ranks include science writers, physicians, lab researchers, market analysts and others inside and outside the hospital.
The UK's equivalent of the FDA has named a prominent British anesthesiologist, Dr. Peter Nightengale as its top medical devices regulator.
The UK's equivalent of the FDA has named a prominent British anesthesiologist as its top medical devices regulator.
Executive recruiter Mike Travis shares his thoughts on how to tell if your candidate will reject your job offer in this excerpt from his book Mastering the Art of Recruiting
By Mike Travis
Excerpted with permission from the author's book, Mastering the Art of Recruiting (Praeger Publishers, January 2015)
When the candidate is motivated to join and you’ve made a reasonable offer, discussions tend to go smoothly and amicably. There’s a spirit of “Let’s make this work.”
Dallen Medical's Tensyn Plug for the treatment of hand and foot injuries wins 510(k) clearance.
The FDA has cleared Dallen Medical Tensyn Plug for the treatment of hand and foot injuries.
3M announced it has entered into an agreement to buy disinfectant-products maker Ivera Medical.
3M Cos. (NYSE:MMM) announced it has entered into an agreement to buy disinfectant-products maker Ivera.
Ivera's lead product, the Curos I.V. port-connector cap, is used to help prevent catheter-related blood-stream infections, or CRBSIs. 3M said the product will complement its Tegaderm line of antimicrobial I.V. securement dressings.
The U.S. Centers for Medicare and Medicaid Services (CMS) has approved a pass-through payment for the Lutonix drug-coated balloon
C.R. Bard (NYSE:BCR) said today that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a pass-through payment for the Lutonix drug-coated balloon, which won FDA approval earlier this month.
